If you're on a drug for high blood pressure or heart failure, it's pretty likely that you're doing your best to keep your ...

A new study from the PARADIGM-HF and PARAGON-HF clinical trials found that sacubitril/valsartan significantly reduced the ...

Mineralys has been on the radar for some biotech investors. Read more about MLYS' hypertension treatment, upcoming trial ...

Valsartan, a drug widely used to control blood pressure is being recalled in several countries around the world because of its chemical ingredient possibly linking to cancer. The drug was ...

Even trace amounts of impurities in medication can spell trouble. Yet, recent research shows that nearly one-third of ...

The findings presented at ESC showed that the use of sacubitril/valsartan (Sac/Val) on top of existing recommended HF therapies prompted a greater N-terminal pro-brain natriuretic peptide ...

Medicare Part D provides coverage for Entresto. Learn more about Medicare drug coverage and the costs of Entresto.

Biocon's subsidiary, Biocon Pharma, has received approval from the US Food and Drug Administration (USFDA) to market a generic version of Sacubitril/Valsartan tablets. This medication addresses ...

Clinicians, researchers, and payer experts convened in Aurora, Colorado, on August 13, 2024, for discussions on ensuring that ...

Bayer's mineralocorticoid receptor antagonist (MRA) Kerendia hit the mark as a treatment for a common form of heart failure ...

Lowering your blood pressure reduces the chance of these disorders happening. Co-Diovan contains valsartan and hydrochlorothiazide. These medicines reduce blood pressure in two different ways.